Brian J. Laight
Kingston, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Quantification and structure-function analysis of calpain-1 and calpain-2 protease subunit interactions.
Journal: The Journal of biological chemistry
Published: February 10, 2025
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses.
Journal: British journal of cancer
Published: October 03, 2023
Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2023
Establishing the role of the FES tyrosine kinase in the pathogenesis, pathophysiology, and severity of sepsis and its outcomes.
Journal: Frontiers in immunology
Published: January 16, 2023
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy-induced Metastasis.
Journal: Cancer research communications
Published: November 03, 2021
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation.
Journal: Journal of cancer research and clinical oncology
Published: December 31, 2020
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.
Journal: Molecular therapy oncolytics
Published: January 21, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026